eGenomics provides its strain library and DNA typing services to pharmaceutical
companies who wish to test new antibiotics, vaccines and other treatment options
against a genetically diverse group of pathogens.
Because the eGenomics system distinguishes among similar pathogens, pharmaceutical companies
can ensure that in vitro testing of new drugs are conducted against dissimilar organisms.